Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Brain : a Journal of Neurology|February 26, 2015
What does it mean to be 'amyloid-positive'?Anne M Fagan
Frontiers in Neurology|July 16, 2015
Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADSuzanne Elizabeth Schindler, Anne M Fagan
Biomarkers in Medicine|August 25, 2012
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, Richard J Perrin
Biomarkers in Medicine|April 3, 2010
Cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, David M Holtzman
Cold Spring Harbor Perspectives in Medicine|September 7, 2012
Fluid biomarkers in Alzheimer diseaseKaj Blennow, Henrik Zetterberg, Anne M Fagan
The Lancet. Neurology|September 13, 2013
Preclinical Alzheimer's disease criteriaAnne M Fagan, Stephanie J B Vos
The Lancet. Neurology|November 25, 2015
Alzheimer's disease biomarker statesStephanie J B Vos, Anne M Fagan
Neurobiology of Disease|November 18, 2008
Biomarkers of Alzheimer's diseaseRebecca Craig-Schapiro, Anne M Fagan, David M Holtzman
Biological Psychiatry|September 10, 2013
Progress update: fluid and imaging biomarkers in Alzheimer's diseaseCourtney L Sutphen, Anne M Fagan, David M Holtzman
Nature|October 16, 2009
Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseRichard J Perrin, Anne M Fagan, David M Holtzman
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Brain : a Journal of Neurology|February 26, 2015
What does it mean to be 'amyloid-positive'?Anne M Fagan
Frontiers in Neurology|July 16, 2015
Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADSuzanne Elizabeth Schindler, Anne M Fagan
Biomarkers in Medicine|August 25, 2012
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, Richard J Perrin
Biomarkers in Medicine|April 3, 2010
Cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, David M Holtzman
Cold Spring Harbor Perspectives in Medicine|September 7, 2012
Fluid biomarkers in Alzheimer diseaseKaj Blennow, Henrik Zetterberg, Anne M Fagan
The Lancet. Neurology|September 13, 2013
Preclinical Alzheimer's disease criteriaAnne M Fagan, Stephanie J B Vos
The Lancet. Neurology|November 25, 2015
Alzheimer's disease biomarker statesStephanie J B Vos, Anne M Fagan
Neurobiology of Disease|November 18, 2008
Biomarkers of Alzheimer's diseaseRebecca Craig-Schapiro, Anne M Fagan, David M Holtzman
Biological Psychiatry|September 10, 2013
Progress update: fluid and imaging biomarkers in Alzheimer's diseaseCourtney L Sutphen, Anne M Fagan, David M Holtzman
Nature|October 16, 2009
Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseRichard J Perrin, Anne M Fagan, David M Holtzman
Pageof 28